In this article, Lee Arian discusses the report that showcased a 2016 law that has dramatically hampered the Drug Enforcement Administration’s (DEA) ability to police prescription opioids before they move into communities. The report includes a tale of profitable drug distributors influencing policy with their lobbying dollars while at the same time recruiting DEA agents over to their ivory towers.
Posted on October 20, 2017
Recent Posts
Harry Nelson Interviewed on NPR: With telehealth abortion, doctors have to learn to trust and empower patientsHarry Nelson Interviewed on BBC News: US to require negative Covid tests for travelers from ChinaNelson Hardiman Ranked 2023 Tier 1 Healthcare Law Firm by U.S. News & World ReportHarry Nelson Interviewed on NewsNation Banfield: Fears over old sports medical forms and girls menstrual informationWith 3 New Additions, Nelson Hardiman Adds to the Leading Healthcare and Life Sciences Law Practice in Los Angeles